07:00 , Apr 28, 2014 |  BC Week In Review  |  Financial News

Aerpio Therapeutics completes venture financing

Aerpio Therapeutics Inc. , Cincinnati, Ohio   Business: Ophthalmic, Autoimmune, Dermatology   Date completed: 4/23/14   Type: Venture financing   Raised: $18 million   Investors: OrbiMed Advisors; Novartis Venture Funds; Satter Investment Management; Kearny Venture...
07:00 , Apr 28, 2014 |  BioCentury  |  Finance

Venture hots up

Private biotechs have raised $3.1 billion since the start of the year, double the $1.5 billion raised in the same period last year. At least one investor contacted by BioCentury expects the pace to continue...
00:33 , Apr 24, 2014 |  BC Extra  |  Financial News

Aerpio raises $18 million in A-2 round

Aerpio Therapeutics Inc. (Cincinnati, Ohio) raised $18 million in a series A-2 round led by new investor OrbiMed. Existing investors Novartis Venture Funds; Satter Investment Management; Kearny Venture Partners; Venture Investors; Triathlon Medical Ventures; and...
08:00 , Nov 11, 2013 |  BC Week In Review  |  Financial News

Aerpio Therapeutics financial update

Aerpio raised $9 million in an extension of a series A round, bringing the total raised to $36 million. The financing was led by Satter Investment Management, with participation from Novartis Venture Funds; Kearney Venture...
07:00 , Jun 10, 2013 |  BC Week In Review  |  Financial News

Akebia completes venture financing

Akebia Therapeutics Inc. , Cincinnati, Ohio   Business: Hematology, Cardiovascular   Date completed: 6/4/13   Type: Venture financing   Raised: $41 million   Investors: Satter Investment Management; Novo A/S; Novartis Venture Funds; Kearny Venture Partners;...
01:00 , Jun 5, 2013 |  BC Extra  |  Top Story

Akebia raises $41 million series C

Anemia company Akebia Therapeutics Inc. (Cincinnati, Ohio) raised $41 million in a series C round co-led by new investors Satter Investment Management and Novo A/S. Existing investors Novartis Venture Fund; Kearny Venture Partners; Venture Investors;...
07:00 , Sep 3, 2012 |  BC Week In Review  |  Financial News

Aerpio Therapeutics completes venture financing

Aerpio Therapeutics Inc. , Cincinnati, Ohio   Business: Ophthalmic, Autoimmune, Dermatology   Date completed: 8/30/12   Type: Venture financing   Raised: $27 million   Investors: Novartis BioVenture Fund; Venture Investors LLC; Triathlon Medical Ventures; Kearney...
00:19 , Aug 31, 2012 |  BC Extra  |  Financial News

Aerpio raises $27M in series A

Aerpio Therapeutics Inc. (Cincinnati, Ohio) raised $27 million in a series A round led by Novartis BioVentures. Venture Investors; Triathlon Medical Ventures; Kearny Venture Partners; Athenian Venture Partners; and AgeChem Venture Fund also participated. Aerpio...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Financial News

Akebia financial update

Akebia raised $4.1 million in a second tranche of a series B round, bringing the total raised in the round to $18.1 million. Existing investors Novartis Venture Funds; Venture Investors; Triathlon Medical Ventures; Kearny Venture...
08:00 , Jan 9, 2012 |  BioCentury  |  Finance

Project management

Project management Akebia Therapeutics Inc. has decided the best way to manage its diverse clinical-stage assets is to spin out a newco - Aerpio Therapeutics Inc. Akebia will focus on anemia, while Aerpio will focus...